HomeHealthcare & Life SciencesBiotechnology Stargardts Treatment Market

United States Stargardts Treatment Market Size & Outlook, 2026-2034


United States Stargardts Treatment Market Insights

  • According to Reed Intelligence analysis, the United States Stargardts Treatment Market size was USD 1174.73 Million in 2025 and is projected to reach USD 3245.7 Million by 2034.
  • The United States market is projected to grow at a CAGR of 11.92% between 2026 and 2034.
  • By segment, Gene Therapy emerged as the largest Treatment Type in terms of market size in 2025.
  • Nutritional and Supportive Therapy is anticipated to remain the most attractive Treatment Type segment, recording the fastest growth during the forecast period.

Other Key Findings


  • In 2025, United States accounted for 29.66% of the global Stargardts Treatment Market size.
  • By 2034, United States is expected to lead the global Stargardts Treatment Market in terms of market size.
  • Within North America, United States is projected to dominate the regional Stargardts Treatment Market size by 2034.
  • United States is identified as the fastest-growing market in North America, anticipated to reach USD 3236.74 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 1174.73 Million
Market Size In 2034 USD 3245.7 Million
Largest segment Gene Therapy
Units Revenue in USD Million
CAGR 11.92% (2026-2034)
Segmnetation Covered
Treatment Type
  1. Gene Therapy
  2. Stem Cell Therapy
  3. Pharmacological Therapy
  4. Nutritional and Supportive Therapy
Disease Stage
  1. Early Stage
  2. Intermediate Stage
  3. Advanced Stage
End-Use
  1. Hospitals and Ophthalmology Clinics
  2. Research Institutes
  3. Specialty Eye Centers
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports